Last reviewed · How we verify
NCT05457114
Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver Transplantation
trial testing Pulmonary artery catheter (Edward Lifesciences, Irvine, California, USA) in End Stage Liver DIsease in 1,970 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,970 |
| Start date | 1 May 2022 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Pulmonary artery catheter (Edward Lifesciences, Irvine, California, USA)
- FloTrac Vigileo system (EV1000 clinical platform, Edward Lifesciences, Irvine, California, USA)
Conditions studied
- End Stage Liver DIsease — all drugs for End Stage Liver DIsease →
- Liver Transplant; Complications — all drugs for Liver Transplant; Complications →
- Liver Cirrhosis — all drugs for Liver Cirrhosis →
- Liver Diseases — all drugs for Liver Diseases →
Sponsor
Seoul National University Hospital
Who can join
20 and older, any sex, with End Stage Liver DIsease or Liver Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators attempted to evaluate whether the use of PAC is associated with better clinical outcomes after liver transplantation compared with the case without PAC.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pulmonary artery catheter monitoring versus arterial waveform-based monitoring during liver transplantation: a retrospective cohort study.
Jung JY, Sohn JY, Lim L, Cho H, et al · · 2023 · cited 2× · PMID 37968287 · DOI 10.1038/s41598-023-46173-1
Verify or expand the search:
- PubMed search for NCT05457114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for End Stage Liver DIsease
Currently open trials in the same condition.
- NCT05205954 — HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease · NA · recruiting
- NCT06455280 — A Study of SIPLIZUMAB in AILD and LT Patients · Phase 1 · recruiting
- NCT06136221 — Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease · NA · recruiting
- NCT05260268 — Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant · NA · recruiting
- NCT05477277 — Adverse Outcomes and Mortality in Liver Transplant · NA · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05457114 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 15 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05457114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing